NO994109L - Oralt preparat for profylaktisk og terapeutisk behandling av Helicobacter sp.-infeksjon - Google Patents

Oralt preparat for profylaktisk og terapeutisk behandling av Helicobacter sp.-infeksjon

Info

Publication number
NO994109L
NO994109L NO994109A NO994109A NO994109L NO 994109 L NO994109 L NO 994109L NO 994109 A NO994109 A NO 994109A NO 994109 A NO994109 A NO 994109A NO 994109 L NO994109 L NO 994109L
Authority
NO
Norway
Prior art keywords
oral preparation
preparation
prophylactic
infection
therapeutic treatment
Prior art date
Application number
NO994109A
Other languages
English (en)
Other versions
NO994109D0 (no
NO327303B1 (no
Inventor
Torkel Wadstroem
Por Alejung
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Publication of NO994109D0 publication Critical patent/NO994109D0/no
Publication of NO994109L publication Critical patent/NO994109L/no
Publication of NO327303B1 publication Critical patent/NO327303B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
NO19994109A 1997-02-27 1999-08-25 Anvendelse av astaxanthin for fremstilling av et preparat for profylaktisk og terapeutisk behandling av Helicobacter sp.-infeksjon NO327303B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
PCT/EP1998/000628 WO1998037874A1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection

Publications (3)

Publication Number Publication Date
NO994109D0 NO994109D0 (no) 1999-08-25
NO994109L true NO994109L (no) 1999-10-27
NO327303B1 NO327303B1 (no) 2009-06-02

Family

ID=20405957

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994109A NO327303B1 (no) 1997-02-27 1999-08-25 Anvendelse av astaxanthin for fremstilling av et preparat for profylaktisk og terapeutisk behandling av Helicobacter sp.-infeksjon

Country Status (15)

Country Link
US (1) US6262316B1 (no)
EP (1) EP0981338B1 (no)
JP (3) JP4267076B2 (no)
KR (1) KR100569908B1 (no)
CN (1) CN1119994C (no)
AT (1) ATE243030T1 (no)
AU (1) AU719090B2 (no)
CA (1) CA2280715C (no)
DE (1) DE69815677D1 (no)
IL (1) IL131129A (no)
NO (1) NO327303B1 (no)
NZ (1) NZ337080A (no)
PL (1) PL335370A1 (no)
SE (1) SE522246C2 (no)
WO (1) WO1998037874A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE524337C2 (sv) * 1998-10-16 2004-07-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7078040B2 (en) 2000-03-27 2006-07-18 Fuji Chemical Industry Co., Ltd. Method of inhibiting the expression of inflammatory cytokines and chemokines
SE0001071D0 (sv) * 2000-03-27 2000-03-27 Astacarotene Ab Method of inhibiting the expression of inflammatory cytokines and chemokines
KR100481880B1 (ko) * 2001-12-05 2005-04-11 (주)바이오벤 목이버섯으로부터 헬리코박터 파이로리의 부착억제성분을추출하는 방법 및 그 헬리코박터 파이로리의 부착억제성분
EP1490040A4 (en) * 2002-01-16 2008-03-05 David Haines INFLAMMATORY FORMULATIONS
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7521584B2 (en) 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
EP2392562B1 (en) 2002-07-29 2018-03-07 Cardax Pharma, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
AU2002329108A1 (en) * 2002-09-03 2004-03-29 Centro De Investigacion En Alimentacion Y Desarrollo A.C. Method of preparing chitosan microcapsules of astaxanthin and product thus obtained
US20040151761A1 (en) * 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
GB0314624D0 (en) 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
WO2005025586A1 (en) 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
WO2005058064A1 (ja) 2003-12-19 2005-06-30 Menicon Co., Ltd. アスタキサンチン配合ペット用食物
EP1750723A1 (en) 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CN1324989C (zh) * 2005-10-10 2007-07-11 华南理工大学 含虾青素营养食品及其制备方法
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP5497372B2 (ja) * 2009-08-19 2014-05-21 バイオジェニック株式会社 非ステロイド性抗炎症薬起因性潰瘍の予防・治療薬
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
CN107691751A (zh) * 2017-11-12 2018-02-16 张雅萍 一种美容、香体的虾青素夹心凝胶糖果及其制备方法
US11065269B1 (en) * 2018-11-15 2021-07-20 Samuel L. Shepherd Method of using astaxanthin for the treatment of diseases, and more particularly, the treatment of cancer
CN114732130B (zh) * 2022-04-07 2024-01-23 云南雨藻生物科技有限公司 含雨生红球藻且抑制胃粘膜受损的组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH0799924A (ja) * 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法
JPH07300421A (ja) 1994-04-28 1995-11-14 Itano Reitou Kk 抗炎症剤
WO1996023489A2 (de) * 1995-02-03 1996-08-08 Basf Aktiengesellschaft Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物

Also Published As

Publication number Publication date
JP4463773B2 (ja) 2010-05-19
KR20000070973A (ko) 2000-11-25
CA2280715C (en) 2008-10-07
AU719090B2 (en) 2000-05-04
WO1998037874A1 (en) 1998-09-03
AU6295198A (en) 1998-09-18
KR100569908B1 (ko) 2006-04-10
CN1119994C (zh) 2003-09-03
SE9700708L (sv) 1998-08-28
CN1248912A (zh) 2000-03-29
NO994109D0 (no) 1999-08-25
US6262316B1 (en) 2001-07-17
DE69815677D1 (de) 2003-07-24
JP2001517213A (ja) 2001-10-02
SE9700708D0 (sv) 1997-02-27
NZ337080A (en) 2001-03-30
EP0981338A1 (en) 2000-03-01
JP2006188526A (ja) 2006-07-20
ATE243030T1 (de) 2003-07-15
CA2280715A1 (en) 1998-09-03
NO327303B1 (no) 2009-06-02
IL131129A (en) 2004-06-20
JP2010111689A (ja) 2010-05-20
PL335370A1 (en) 2000-04-25
JP4267076B2 (ja) 2009-05-27
EP0981338B1 (en) 2003-06-18
IL131129A0 (en) 2001-01-28
SE522246C2 (sv) 2004-01-27

Similar Documents

Publication Publication Date Title
NO994109D0 (no) Oralt preparat for profylaktisk og terapeutisk behandling av Helicobacter sp.-infeksjon
EP1370564B1 (en) Resveratrol-phospholipids complexes
US20050282781A1 (en) Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
CA2314170A1 (en) Method of the prophylactic treatment of mastitis
JPH0657659B2 (ja) 消化管にて種々のレベルで消化促進剤として作用する酵素組成物
ATE269065T1 (de) Behandlung von verdauungsstörungen
JPH11139947A (ja) マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
GB2238476A (en) Therapeutic aquatic animal and garlic products
ES2251948T3 (es) Preparacion de un medicamento que contiene compuestos polifenolicos de tipo catequico o flavonicos de origen vegetal, en particular para el tratamiento de las gingivitis.
RU2118528C1 (ru) Композиция для приготовления лекарственных форм и обогащения продуктов питания "каролин"
Chandrashekar Comparative study on the efficacy of Topical Curcumin as a gel and as Buccal Mucoadhesive Patch in the management of oral Submucous Fibrosis-A clinicobiochemical evaluation
PT1677628E (pt) Composição para activação do sistema imunitário
WO2007116432A1 (ja) キャノロールまたはそのプロドラッグ（ｐｄ）を含む抗炎症剤および癌予防剤ならびにこれらを含む医薬、化粧品および食品
Jones Prospects for peptic ulcer prevention
Capasso et al. Stimulated human colonic synthesis of arachidonate lipoxygenase and cyclo-oxygenase products by laxatives
EP0272057A3 (en) Pharmaceutical compositions containing pyranoquinolines

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees